South Korea Ligases Market Size & Outlook, 2023-2030
Related Markets
South Korea ligases market highlights
- The South Korea ligases market generated a revenue of USD 10.1 million in 2023 and is expected to reach USD 18.4 million by 2030.
- The South Korea market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, other applications was the largest revenue generating application in 2023.
- Other Applications is the most lucrative application segment registering the fastest growth during the forecast period.
Ligases market data book summary
| Market revenue in 2023 | USD 10.1 million |
| Market revenue in 2030 | USD 18.4 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Other applications |
| Fastest growing segment | Other Applications |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotide synthesis, Other Applications |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Promega, New England Biolabs, RayBiotech, Qiagen NV, Takara Bio Inc, Abnova, Worthington Enterprises Inc, MyBiosource, Sino Biological, Biovision, Calzyme, ArcticZymes Technologies, MBL International Corporation, BPS Bioscience Inc., Bio-Techne Corp, ABclonal |
Other key industry trends
- In terms of revenue, South Korea accounted for 4.1% of the global ligases market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ligases market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 28.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ligases Market Scope
Ligases Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ABclonal | View profile | 501-1000 | Wuhan, Hubei, China, Asia | https://abclonal.com/ |
| MBL International Corporation | View profile | 101-250 | Woburn, Massachusetts, United States, North America | https://www.mblintl.com/ |
| ArcticZymes Technologies | View profile | 11-50 | Tromsø, Troms, Norway, Europe | https://arcticzymes.com/ |
| Calzyme | View profile | 11-50 | San Luis Obispo, California, United States, North America | https://www.calzyme.com |
| Biovision | View profile | 51-100 | Milpitas, California, United States, North America | https://www.biovision.com |
| BPS Bioscience Inc. | View profile | 51-100 | San Diego, California, United States, North America | http://bpsbioscience.com |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| Abnova | View profile | 251-500 | Taipei, T'ai-pei, Taiwan, Asia | http://www.abnova.com/ |
| Worthington Enterprises Inc | View profile | 8200 | 200 Old Wilson Bridge Road, Columbus, OH, United States, 43085 | https://www.worthingtonindustries.com |
| MyBiosource | View profile | 11-50 | San Diego, California, United States, North America | https://www.mybiosource.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Sino Biological | View profile | 251-500 | Beijing, Beijing, China, Asia | http://www.sinobiological.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
South Korea ligases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ligases market will help companies and investors design strategic landscapes.
Other applications was the largest segment with a revenue share of 56.44% in 2023. Horizon Databook has segmented the South Korea ligases market based on oligonucleotide synthesis, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea ligases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea ligases market databook
-
Our clientele includes a mix of ligases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea ligases market, including forecasts for subscribers. This country databook contains high-level insights into South Korea ligases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea Application - Ligases Market, 2023 - 2030 (US$M)
South Korea Ligases Market Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
